Higher costs headline list of new challenges faced by CROs and sponsors.
Michael Sigmund
Advertisement
Articles by Michael Sigmund
An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
Advertisement
Latest Updated Articles
RBM—An Update of Experiences Among European CRAsPublished: October 20th 2017 | Updated:
Consequences of Brexit for Clinical Trials in EuropePublished: October 14th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
3
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
4
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
